Sign in
Geographic Trends in the Recruitment of Participants of Racial and Ethnic Minorities for Diabetic Retinopathy-Related Clinical Trials
Vivienne S. Hau, MD, PhD
Annual Meeting Talks
2023
Baseline Characteristics of Patients Who Did or Did Not Maintain 12-Week and 16-Week Aflibercept 8 mg Dosing Intervals in the Phase 2/3 PHOTON Trial
Eric W Schneider, MD
Long-Term Outcome of Diabetic Eyes With Vitreous Hemorrhage in an Urban Safety-Net Hospital
Hossein Ameri, MD, PhD, FRCSI, MRCOphth
2024
Category: Imaging